首頁 > 市場調查報告書 > 食物/飲料

食品添加劑機能性食品

半胱胺酸市場規模、佔有率和成長分析（按類型、形態、等級、最終用途產業和地區分類）－2025-2032年產業預測

市場調查報告書

商品編碼

1865381

半胱胺酸市場規模、佔有率和成長分析（按類型、形態、等級、最終用途產業和地區分類）－2025-2032年產業預測

Cysteine Market Size, Share, and Growth Analysis, By Type (L-Cysteine, D-Cysteine), By Form (Powder, Liquid), By Grade, By End Use Industry, By Region - Industry Forecast 2025-2032

出版日期: 2025年11月06日 | 出版商:

SkyQuest | 英文 187 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2023 年，全球半胱胺酸市場規模將達到 5.693 億美元，到 2024 年將成長至 6.1769 億美元，到 2032 年將成長至 11.8634 億美元，預測期（2025-2032 年）的複合年成長率為 8.5%。

受食品、醫藥和個人護理行業需求成長的推動，全球半胱氨酸市場正經歷強勁成長。發酵和酶促合成技術的創新實現了永續且經濟高效的生產方法，減少了對動物性成分的依賴。半胱氨酸在食品加工中發揮關鍵作用，有助於提升烘焙點心和鹹味食品的風味和口感。人們對呼吸系統健康和免疫力的日益關注也促使半胱氨酸在醫藥領域得到更廣泛的應用，尤其是在祛痰藥和膳食補充劑方面。此外，包封技術的進步提高了半胱氨酸作為膳食補充劑成分的穩定性和保存期限。由於健康意識的增強以及對食品和醫藥基礎設施的大量投資，亞太和拉丁美洲等新興市場預計將更快地採用半胱氨酸。

全球半胱氨酸市場促進因素

全球半胱胺酸市場的主要驅動力是各行業（包括製藥、食品和動物營養）對胺基酸需求的不斷成長。半胱氨酸是蛋白質的重要組成部分，在促進健康方面發揮關鍵作用。人們對半胱氨酸益處的認知不斷提高，例如其抗氧化特性、促進皮膚健康和增強免疫功能，這正在推動消費者對半胱氨酸的興趣。此外，膳食補充劑行業的擴張和健康飲食趨勢的興起也推動了對富含半胱氨酸產品的需求，從而促進了市場成長。

限制全球半胱氨酸市場的因素

全球半胱氨酸市場的主要限制因素是其提取和合成的高昂生產成本。包括動物性蛋白質和發酵過程在內的半胱氨酸主要來源需要大量的資源投入和營運成本。此外，食品、化妝品和藥品領域對半胱氨酸使用的嚴格監管要求，可能會因核准週期長和合規成本高而阻礙市場成長。這些因素可能會阻礙新進入者，並限制現有生產商擴大業務的能力，最終限制市場供應並影響定價策略。

全球半胱氨酸市場趨勢

隨著消費者越來越重視未經動物測試的天然成分，全球半胱氨酸市場正經歷著向潔淨標示和純素友善成分的顯著轉變。這種日益成長的需求促使食品生產商優先選擇發酵衍生的L-半胱氨酸，而非傳統的動物性和合成來源。隨著市場的發展，生產商正迅速採用符合猶太潔食、清真食品和純素認證標準的生物發酵平台，這反映了食品生產向符合倫理和永續發展的更廣泛趨勢。這種轉變不僅滿足了消費者對透明度和健康的偏好，而且在競爭日益激烈的環境中也有助於培養品牌忠誠度，最終推動了半胱氨酸市場的成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2024 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2024 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2022-2024年營收年比比較

主要企業簡介

Wacker Chemie AG（Germany）
Ajinomoto Co., Inc.（Japan）
CJ CheilJedang Corp.（South Korea）
Evonik Industries AG（Germany）
Merck KGaA（Germany）
NIPPON RIKA CO., LTD.（Japan）
Taenaka Kogyo Co., Ltd.（Japan）
Bachem（Switzerland）
Donboo Amino Acid Co., Ltd.（China）
Shine Star Biological Engineering Co., Ltd.（China）
Wuhan Grand Hoyo Co., Ltd.（China）
Wuxi Bikang Bioengineering Co., Ltd.（China）
Hebei Huaheng Biological Technology Co., Ltd.（China）
Fengchen Group Co., Ltd.（China）
Zhejiang NHU Co., Ltd.（China）
Hubei Bafeng Pharmaceuticals Co., Ltd.（China）
Cosroma（China）
Glentham Life Sciences Limited（United Kingdom）
Central Drug House（India）
AB Enterprises（India）

結論與建議

簡介目錄

Product Code: SQMIG15E2960

Global Cysteine Market size was valued at USD 569.3 million in 2023 and is poised to grow from USD 617.69 million in 2024 to USD 1186.34 million by 2032, growing at a CAGR of 8.5% during the forecast period (2025-2032).

The global cysteine market is experiencing robust growth, fueled by rising demands across food, pharmaceutical, and personal care sectors. Innovations in fermentation and enzymatic synthesis technologies are enabling sustainable, cost-effective production methods, reducing reliance on animal-derived sources. Cysteine plays a crucial role in food processing, enhancing flavors and improving dough conditions in baked goods and savory items. Its pharmaceutical applications, particularly in mucolytic drugs and dietary supplements, are expanding as awareness of respiratory health and immunity rises. Additionally, advancements in encapsulation technologies are enhancing its stability and shelf life as a nutraceutical ingredient. Emerging markets, notably in Asia-Pacific and Latin America, are likely to adopt cysteine more rapidly due to increasing health awareness and substantial investments in food and pharmaceutical infrastructures.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cysteine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cysteine Market Segments Analysis

Global Cysteine Market is segmented by Type, Form, Grade, End Use Industry and region. Based on Type, the market is segmented into L-Cysteine, D-Cysteine and DL-Cysteine. Based on Form, the market is segmented into Powder, Liquid and Crystals. Based on Grade, the market is segmented into Pharmaceutical Grade, Food Grade and Cosmetic Grade. Based on End Use Industry, the market is segmented into Pharmaceuticals, Food and Beverages and Personal Care and Cosmetics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cysteine Market

A key market driver for the global cysteine market is the increasing demand for amino acids in various industries, particularly in pharmaceuticals, food, and animal nutrition. Cysteine, as a crucial building block of proteins, plays a significant role in enhancing health and wellness. The growing awareness of the benefits associated with cysteine, such as its antioxidant properties and its effectiveness in promoting skin health and improving immune function, is driving consumer interest. Furthermore, the expansion of the dietary supplement sector and the rising trend of health-conscious eating are fueling the demand for cysteine-rich products, thus bolstering market growth.

Restraints in the Global Cysteine Market

A significant market restraint for the global cysteine market is the high production cost associated with its extraction and synthesis. The primary sources of cysteine, including animal proteins and fermentation processes, entail substantial resource inputs and operational expenses. Additionally, stringent regulatory requirements surrounding the use of cysteine in food, cosmetics, and pharmaceuticals can impede the market's growth by lengthening approval timelines and increasing compliance costs. These factors may deter new entrants and limit the capacity of existing producers to scale operations, ultimately constraining market supply and impacting pricing strategies.

Market Trends of the Global Cysteine Market

The global cysteine market is witnessing a notable shift towards clean-label and vegan sourcing as consumers increasingly prioritize cruelty-free and natural ingredients. This rising demand is prompting food producers to favor fermentation-based L-cysteine over traditional animal-derived and synthetic sources. As the market evolves, manufacturers are rapidly adopting bio-fermentation platforms that meet the standards of kosher, halal, and vegan certifications, reflecting a broader trend towards ethical and sustainable food production. This transition not only caters to consumer preferences for transparency and health but also enhances brand loyalty in an increasingly competitive landscape, ultimately driving growth in the cysteine market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Cysteine Market Size by Type & CAGR (2025-2032)

Market Overview
L-Cysteine
D-Cysteine
DL-Cysteine

Global Cysteine Market Size by Form & CAGR (2025-2032)

Market Overview
Powder
Liquid
Crystals

Global Cysteine Market Size by Grade & CAGR (2025-2032)

Market Overview
Pharmaceutical Grade
Food Grade
Cosmetic Grade

Global Cysteine Market Size by End Use Industry & CAGR (2025-2032)

Market Overview
Pharmaceuticals
Food and Beverages
Personal Care and Cosmetics

Global Cysteine Market Size & CAGR (2025-2032)

North America (Type, Form, Grade, End Use Industry)
- US
- Canada
Europe (Type, Form, Grade, End Use Industry)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Form, Grade, End Use Industry)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Form, Grade, End Use Industry)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Form, Grade, End Use Industry)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Wacker Chemie AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ajinomoto Co., Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CJ CheilJedang Corp. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evonik Industries AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NIPPON RIKA CO., LTD. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taenaka Kogyo Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bachem (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Donboo Amino Acid Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shine Star Biological Engineering Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wuhan Grand Hoyo Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wuxi Bikang Bioengineering Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hebei Huaheng Biological Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fengchen Group Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zhejiang NHU Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hubei Bafeng Pharmaceuticals Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cosroma (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glentham Life Sciences Limited (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Central Drug House (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
A B Enterprises (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments